C Lechner, M Flaßhoff, H Falke, L Preu, N Loaëc… - Molecules, 2019 - ncbi.nlm.nih.gov
Since hyperactivity of the protein kinase DYRK1A is linked to several neurodegenerative
disorders, DYRK1A inhibitors have been suggested as potential therapeutics for Down …